HEADER IMMUNE SYSTEM 05-NOV-03 1RD4 TITLE AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRIN ALPHA-L; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: I DOMAIN, RESIDUES 125-311; COMPND 5 SYNONYM: LEUKOCYTE ADHESION GLYCOPROTEIN LFA-1 ALPHA CHAIN, LEUKOCYTE COMPND 6 FUNCTION ASSOCIATED MOLECULE 1 ALPHA CHAIN, CD11A; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ITGAL, CD11A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR M.P.CRUMP,T.A.CESKA,L.SPYRACOPOULOS,A.HENRY,S.C.ARCHIBALD, AUTHOR 2 R.ALEXANDER,R.J.TAYLOR,S.C.FINDLOW,J.O'CONNELL,M.K.ROBINSON,A.SHOCK REVDAT 4 23-AUG-23 1RD4 1 REMARK SEQADV REVDAT 3 04-APR-18 1RD4 1 REMARK REVDAT 2 24-FEB-09 1RD4 1 VERSN REVDAT 1 30-MAR-04 1RD4 0 JRNL AUTH M.P.CRUMP,T.A.CESKA,L.SPYRACOPOULOS,A.HENRY,S.C.ARCHIBALD, JRNL AUTH 2 R.ALEXANDER,R.J.TAYLOR,S.C.FINDLOW,J.O'CONNELL,M.K.ROBINSON, JRNL AUTH 3 A.SHOCK JRNL TITL STRUCTURE OF AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO THE JRNL TITL 2 I-DOMAIN STUDIED BY CRYSTALLOGRAPHY, NMR, AND CALORIMETRY JRNL REF BIOCHEMISTRY V. 43 2394 2004 JRNL REFN ISSN 0006-2960 JRNL PMID 14992576 JRNL DOI 10.1021/BI035422A REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 26155 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2615 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5916 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 136 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RD4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-NOV-03. REMARK 100 THE DEPOSITION ID IS D_1000020661. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-OCT-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26155 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.6 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1LFA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% (W/V) PEG 4000, 0.2M AMMONIUM REMARK 280 ACETATE, 0.1M SODIUM ACETATE, PH 4.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 121 REMARK 465 ALA A 122 REMARK 465 MET A 123 REMARK 465 SER A 124 REMARK 465 CYS A 125 REMARK 465 ILE A 126 REMARK 465 LYS A 127 REMARK 465 GLY B 121 REMARK 465 ALA B 122 REMARK 465 MET B 123 REMARK 465 SER B 124 REMARK 465 CYS B 125 REMARK 465 ILE B 126 REMARK 465 LYS B 127 REMARK 465 GLY C 121 REMARK 465 ALA C 122 REMARK 465 MET C 123 REMARK 465 SER C 124 REMARK 465 CYS C 125 REMARK 465 ILE C 126 REMARK 465 LYS C 127 REMARK 465 GLY D 121 REMARK 465 ALA D 122 REMARK 465 MET D 123 REMARK 465 SER D 124 REMARK 465 CYS D 125 REMARK 465 ILE D 126 REMARK 465 LYS D 127 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 164 -167.09 -111.87 REMARK 500 SER A 174 -109.61 -151.60 REMARK 500 SER A 176 -167.88 -114.73 REMARK 500 LYS A 190 -53.27 71.42 REMARK 500 ASP A 191 109.65 -49.72 REMARK 500 LEU A 204 -136.59 -118.93 REMARK 500 THR B 164 -166.42 -114.45 REMARK 500 SER B 174 -108.63 -152.74 REMARK 500 SER B 176 -167.94 -116.44 REMARK 500 LYS B 190 -54.94 73.10 REMARK 500 LEU B 204 -137.24 -118.29 REMARK 500 THR C 164 -164.83 -114.80 REMARK 500 SER C 174 -107.29 -152.87 REMARK 500 SER C 176 -165.59 -115.13 REMARK 500 LYS C 190 -52.25 69.83 REMARK 500 ASP C 191 108.97 -50.33 REMARK 500 LEU C 204 -133.23 -119.78 REMARK 500 THR D 164 -166.52 -114.47 REMARK 500 SER D 174 -109.52 -154.67 REMARK 500 SER D 176 -169.99 -116.65 REMARK 500 LYS D 190 -56.28 71.33 REMARK 500 ASP D 191 109.16 -46.81 REMARK 500 LEU D 204 -136.34 -117.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L08 A 328 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L08 B 1328 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L08 C 2328 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L08 D 3328 DBREF 1RD4 A 125 311 UNP P20701 ITAL_HUMAN 150 336 DBREF 1RD4 B 125 311 UNP P20701 ITAL_HUMAN 150 336 DBREF 1RD4 C 125 311 UNP P20701 ITAL_HUMAN 150 336 DBREF 1RD4 D 125 311 UNP P20701 ITAL_HUMAN 150 336 SEQADV 1RD4 GLY A 121 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 ALA A 122 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 MET A 123 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 SER A 124 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 GLY B 121 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 ALA B 122 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 MET B 123 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 SER B 124 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 GLY C 121 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 ALA C 122 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 MET C 123 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 SER C 124 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 GLY D 121 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 ALA D 122 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 MET D 123 UNP P20701 CLONING ARTIFACT SEQADV 1RD4 SER D 124 UNP P20701 CLONING ARTIFACT SEQRES 1 A 191 GLY ALA MET SER CYS ILE LYS GLY ASN VAL ASP LEU VAL SEQRES 2 A 191 PHE LEU PHE ASP GLY SER MET SER LEU GLN PRO ASP GLU SEQRES 3 A 191 PHE GLN LYS ILE LEU ASP PHE MET LYS ASP VAL MET LYS SEQRES 4 A 191 LYS LEU SER ASN THR SER TYR GLN PHE ALA ALA VAL GLN SEQRES 5 A 191 PHE SER THR SER TYR LYS THR GLU PHE ASP PHE SER ASP SEQRES 6 A 191 TYR VAL LYS ARG LYS ASP PRO ASP ALA LEU LEU LYS HIS SEQRES 7 A 191 VAL LYS HIS MET LEU LEU LEU THR ASN THR PHE GLY ALA SEQRES 8 A 191 ILE ASN TYR VAL ALA THR GLU VAL PHE ARG GLU GLU LEU SEQRES 9 A 191 GLY ALA ARG PRO ASP ALA THR LYS VAL LEU ILE ILE ILE SEQRES 10 A 191 THR ASP GLY GLU ALA THR ASP SER GLY ASN ILE ASP ALA SEQRES 11 A 191 ALA LYS ASP ILE ILE ARG TYR ILE ILE GLY ILE GLY LYS SEQRES 12 A 191 HIS PHE GLN THR LYS GLU SER GLN GLU THR LEU HIS LYS SEQRES 13 A 191 PHE ALA SER LYS PRO ALA SER GLU PHE VAL LYS ILE LEU SEQRES 14 A 191 ASP THR PHE GLU LYS LEU LYS ASP LEU PHE THR GLU LEU SEQRES 15 A 191 GLN LYS LYS ILE TYR VAL ILE GLU GLY SEQRES 1 B 191 GLY ALA MET SER CYS ILE LYS GLY ASN VAL ASP LEU VAL SEQRES 2 B 191 PHE LEU PHE ASP GLY SER MET SER LEU GLN PRO ASP GLU SEQRES 3 B 191 PHE GLN LYS ILE LEU ASP PHE MET LYS ASP VAL MET LYS SEQRES 4 B 191 LYS LEU SER ASN THR SER TYR GLN PHE ALA ALA VAL GLN SEQRES 5 B 191 PHE SER THR SER TYR LYS THR GLU PHE ASP PHE SER ASP SEQRES 6 B 191 TYR VAL LYS ARG LYS ASP PRO ASP ALA LEU LEU LYS HIS SEQRES 7 B 191 VAL LYS HIS MET LEU LEU LEU THR ASN THR PHE GLY ALA SEQRES 8 B 191 ILE ASN TYR VAL ALA THR GLU VAL PHE ARG GLU GLU LEU SEQRES 9 B 191 GLY ALA ARG PRO ASP ALA THR LYS VAL LEU ILE ILE ILE SEQRES 10 B 191 THR ASP GLY GLU ALA THR ASP SER GLY ASN ILE ASP ALA SEQRES 11 B 191 ALA LYS ASP ILE ILE ARG TYR ILE ILE GLY ILE GLY LYS SEQRES 12 B 191 HIS PHE GLN THR LYS GLU SER GLN GLU THR LEU HIS LYS SEQRES 13 B 191 PHE ALA SER LYS PRO ALA SER GLU PHE VAL LYS ILE LEU SEQRES 14 B 191 ASP THR PHE GLU LYS LEU LYS ASP LEU PHE THR GLU LEU SEQRES 15 B 191 GLN LYS LYS ILE TYR VAL ILE GLU GLY SEQRES 1 C 191 GLY ALA MET SER CYS ILE LYS GLY ASN VAL ASP LEU VAL SEQRES 2 C 191 PHE LEU PHE ASP GLY SER MET SER LEU GLN PRO ASP GLU SEQRES 3 C 191 PHE GLN LYS ILE LEU ASP PHE MET LYS ASP VAL MET LYS SEQRES 4 C 191 LYS LEU SER ASN THR SER TYR GLN PHE ALA ALA VAL GLN SEQRES 5 C 191 PHE SER THR SER TYR LYS THR GLU PHE ASP PHE SER ASP SEQRES 6 C 191 TYR VAL LYS ARG LYS ASP PRO ASP ALA LEU LEU LYS HIS SEQRES 7 C 191 VAL LYS HIS MET LEU LEU LEU THR ASN THR PHE GLY ALA SEQRES 8 C 191 ILE ASN TYR VAL ALA THR GLU VAL PHE ARG GLU GLU LEU SEQRES 9 C 191 GLY ALA ARG PRO ASP ALA THR LYS VAL LEU ILE ILE ILE SEQRES 10 C 191 THR ASP GLY GLU ALA THR ASP SER GLY ASN ILE ASP ALA SEQRES 11 C 191 ALA LYS ASP ILE ILE ARG TYR ILE ILE GLY ILE GLY LYS SEQRES 12 C 191 HIS PHE GLN THR LYS GLU SER GLN GLU THR LEU HIS LYS SEQRES 13 C 191 PHE ALA SER LYS PRO ALA SER GLU PHE VAL LYS ILE LEU SEQRES 14 C 191 ASP THR PHE GLU LYS LEU LYS ASP LEU PHE THR GLU LEU SEQRES 15 C 191 GLN LYS LYS ILE TYR VAL ILE GLU GLY SEQRES 1 D 191 GLY ALA MET SER CYS ILE LYS GLY ASN VAL ASP LEU VAL SEQRES 2 D 191 PHE LEU PHE ASP GLY SER MET SER LEU GLN PRO ASP GLU SEQRES 3 D 191 PHE GLN LYS ILE LEU ASP PHE MET LYS ASP VAL MET LYS SEQRES 4 D 191 LYS LEU SER ASN THR SER TYR GLN PHE ALA ALA VAL GLN SEQRES 5 D 191 PHE SER THR SER TYR LYS THR GLU PHE ASP PHE SER ASP SEQRES 6 D 191 TYR VAL LYS ARG LYS ASP PRO ASP ALA LEU LEU LYS HIS SEQRES 7 D 191 VAL LYS HIS MET LEU LEU LEU THR ASN THR PHE GLY ALA SEQRES 8 D 191 ILE ASN TYR VAL ALA THR GLU VAL PHE ARG GLU GLU LEU SEQRES 9 D 191 GLY ALA ARG PRO ASP ALA THR LYS VAL LEU ILE ILE ILE SEQRES 10 D 191 THR ASP GLY GLU ALA THR ASP SER GLY ASN ILE ASP ALA SEQRES 11 D 191 ALA LYS ASP ILE ILE ARG TYR ILE ILE GLY ILE GLY LYS SEQRES 12 D 191 HIS PHE GLN THR LYS GLU SER GLN GLU THR LEU HIS LYS SEQRES 13 D 191 PHE ALA SER LYS PRO ALA SER GLU PHE VAL LYS ILE LEU SEQRES 14 D 191 ASP THR PHE GLU LYS LEU LYS ASP LEU PHE THR GLU LEU SEQRES 15 D 191 GLN LYS LYS ILE TYR VAL ILE GLU GLY HET L08 A 328 34 HET L08 B1328 34 HET L08 C2328 34 HET L08 D3328 34 HETNAM L08 1-ACETYL-4-(4-{4-[(2-ETHOXYPHENYL)THIO]-3- HETNAM 2 L08 NITROPHENYL}PYRIDIN-2-YL)PIPERAZINE FORMUL 5 L08 4(C25 H26 N4 O4 S) HELIX 1 1 GLN A 143 LEU A 161 1 19 HELIX 2 2 ASP A 182 LYS A 190 1 9 HELIX 3 3 ASP A 191 LEU A 196 1 6 HELIX 4 4 ASN A 207 VAL A 219 1 13 HELIX 5 5 ARG A 221 GLY A 225 5 5 HELIX 6 6 ILE A 248 LYS A 252 5 5 HELIX 7 7 LYS A 263 GLN A 266 5 4 HELIX 8 8 THR A 267 THR A 273 1 7 HELIX 9 9 PRO A 281 PHE A 285 1 5 HELIX 10 10 GLU A 293 LYS A 304 1 12 HELIX 11 11 GLN B 143 LEU B 161 1 19 HELIX 12 12 ASP B 182 LYS B 190 1 9 HELIX 13 13 ASP B 191 LEU B 196 1 6 HELIX 14 14 ASN B 207 VAL B 219 1 13 HELIX 15 15 ARG B 221 GLY B 225 5 5 HELIX 16 16 ILE B 248 LYS B 252 5 5 HELIX 17 17 LYS B 263 GLN B 266 5 4 HELIX 18 18 THR B 267 THR B 273 1 7 HELIX 19 19 PRO B 281 PHE B 285 1 5 HELIX 20 20 GLU B 293 LYS B 304 1 12 HELIX 21 21 GLN C 143 LEU C 161 1 19 HELIX 22 22 ASP C 182 LYS C 190 1 9 HELIX 23 23 ASP C 191 LEU C 196 1 6 HELIX 24 24 ASN C 207 VAL C 219 1 13 HELIX 25 25 ARG C 221 GLY C 225 5 5 HELIX 26 26 ILE C 248 LYS C 252 5 5 HELIX 27 27 LYS C 263 GLN C 266 5 4 HELIX 28 28 THR C 267 THR C 273 1 7 HELIX 29 29 PRO C 281 PHE C 285 1 5 HELIX 30 30 GLU C 293 LYS C 304 1 12 HELIX 31 31 GLN D 143 LEU D 161 1 19 HELIX 32 32 ASP D 182 LYS D 190 1 9 HELIX 33 33 ASP D 191 LEU D 196 1 6 HELIX 34 34 ASN D 207 VAL D 219 1 13 HELIX 35 35 ARG D 221 GLY D 225 5 5 HELIX 36 36 ILE D 248 LYS D 252 5 5 HELIX 37 37 LYS D 263 GLN D 266 5 4 HELIX 38 38 THR D 267 THR D 273 1 7 HELIX 39 39 PRO D 281 PHE D 285 1 5 HELIX 40 40 GLU D 293 LYS D 304 1 12 SHEET 1 A 6 TYR A 177 PHE A 181 0 SHEET 2 A 6 TYR A 166 PHE A 173 -1 N GLN A 172 O LYS A 178 SHEET 3 A 6 VAL A 130 ASP A 137 1 N PHE A 134 O VAL A 171 SHEET 4 A 6 THR A 231 THR A 238 1 O ILE A 235 N VAL A 133 SHEET 5 A 6 ILE A 255 ILE A 261 1 O TYR A 257 N ILE A 236 SHEET 6 A 6 VAL A 286 LEU A 289 1 O LEU A 289 N GLY A 260 SHEET 1 B 6 TYR B 177 PHE B 181 0 SHEET 2 B 6 TYR B 166 PHE B 173 -1 N GLN B 172 O LYS B 178 SHEET 3 B 6 VAL B 130 ASP B 137 1 N PHE B 134 O VAL B 171 SHEET 4 B 6 THR B 231 THR B 238 1 O VAL B 233 N ASP B 131 SHEET 5 B 6 ILE B 255 ILE B 261 1 O TYR B 257 N ILE B 236 SHEET 6 B 6 VAL B 286 LEU B 289 1 O LEU B 289 N GLY B 260 SHEET 1 C 6 TYR C 177 PHE C 181 0 SHEET 2 C 6 TYR C 166 PHE C 173 -1 N GLN C 172 O LYS C 178 SHEET 3 C 6 VAL C 130 ASP C 137 1 N PHE C 134 O VAL C 171 SHEET 4 C 6 THR C 231 THR C 238 1 O ILE C 235 N VAL C 133 SHEET 5 C 6 ILE C 255 ILE C 261 1 O TYR C 257 N ILE C 236 SHEET 6 C 6 VAL C 286 LEU C 289 1 O LEU C 289 N GLY C 260 SHEET 1 D 2 ILE C 306 VAL C 308 0 SHEET 2 D 2 ILE D 306 VAL D 308 -1 O TYR D 307 N TYR C 307 SHEET 1 E 6 TYR D 177 PHE D 181 0 SHEET 2 E 6 TYR D 166 PHE D 173 -1 N GLN D 172 O LYS D 178 SHEET 3 E 6 VAL D 130 ASP D 137 1 N PHE D 134 O VAL D 171 SHEET 4 E 6 THR D 231 THR D 238 1 O VAL D 233 N VAL D 133 SHEET 5 E 6 ILE D 255 ILE D 261 1 O TYR D 257 N ILE D 236 SHEET 6 E 6 VAL D 286 LEU D 289 1 O LEU D 289 N GLY D 260 CISPEP 1 LYS A 280 PRO A 281 0 0.27 CISPEP 2 LYS B 280 PRO B 281 0 0.10 CISPEP 3 LYS C 280 PRO C 281 0 0.19 CISPEP 4 LYS D 280 PRO D 281 0 -0.03 SITE 1 AC1 18 PHE A 153 VAL A 157 TYR A 166 VAL A 233 SITE 2 AC1 18 ILE A 235 ILE A 255 TYR A 257 ILE A 258 SITE 3 AC1 18 ILE A 259 GLU A 284 PHE A 285 VAL A 286 SITE 4 AC1 18 LYS A 287 LEU A 298 GLU A 301 LEU A 302 SITE 5 AC1 18 LYS A 305 VAL B 308 SITE 1 AC2 17 VAL A 308 PHE B 153 VAL B 157 TYR B 166 SITE 2 AC2 17 VAL B 233 ILE B 235 TYR B 257 ILE B 258 SITE 3 AC2 17 ILE B 259 GLU B 284 PHE B 285 VAL B 286 SITE 4 AC2 17 LYS B 287 LEU B 298 GLU B 301 LEU B 302 SITE 5 AC2 17 LYS B 305 SITE 1 AC3 17 PHE C 134 PHE C 153 TYR C 166 VAL C 233 SITE 2 AC3 17 ILE C 235 ILE C 255 TYR C 257 ILE C 258 SITE 3 AC3 17 ILE C 259 GLU C 284 PHE C 285 VAL C 286 SITE 4 AC3 17 LYS C 287 LEU C 298 GLU C 301 LEU C 302 SITE 5 AC3 17 VAL D 308 SITE 1 AC4 16 VAL C 308 PHE D 153 VAL D 157 TYR D 166 SITE 2 AC4 16 VAL D 233 ILE D 235 ILE D 255 TYR D 257 SITE 3 AC4 16 ILE D 258 ILE D 259 GLU D 284 PHE D 285 SITE 4 AC4 16 VAL D 286 LYS D 287 LEU D 298 GLU D 301 CRYST1 45.960 64.410 66.210 74.21 90.00 87.26 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021758 -0.001041 0.000295 0.00000 SCALE2 0.000000 0.015543 -0.004401 0.00000 SCALE3 0.000000 0.000000 0.015697 0.00000